Compass Pathways is considered a frontrunner in the race to obtain the first approval for a psychedelic drug. However, competition is intensifying as a non-profit organization is also advancing its own efforts in this area. The outcome of this race could have significant implications for the biotech sector, particularly in how psychedelic therapies are integrated into treatment protocols and the potential market opportunities that may arise for successful developers.
Source: statnews.com · Image: Stanford Psychedelics — 1967 (52482248021) by Steve Jurvetson from Los Altos, USA, CC BY 2.0, via Wikimedia Commons
Planning your supply chain?
The API & FDF Intelligence database shows where manufacturers are located, which certificates they hold, and which markets are overheated.
With direct contacts for every supplier and holder, you can move from weeks of outreach to decisions made in hours.
Use the database as your supply chain compass →
Use the database as your supply chain compass →
